However, there was an observed reduction in tumor development in the PRCC‐TFE3 KI/Hif1α KO group (Figure 4C,G) and PRCC‐TFE3 KI/Hif1α/Hif2α DKO group (Figure 4E,I). The gene discussed is HIF1A; the disease is neoplasm.